Skip to content

Study · Not a test of the peptide alone · 2011

2 results

[Biotechnological production of acetylated thymosin beta4].

Beĭrakhova KA, Stepanenko VN, Miroshnikov AI, Esipov RS

Bioorganicheskaia khimiia1 Mar 2011Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Other

    N-terminal acetylation of desacetylthymosin beta4 with acetic anhydride at pH 3 gave a reaction yield of 55%.

    In plain wordsIn lab work, the chemical acetylation step of thymosin beta‑4 production had a yield of 55%.

    Outcome
    Not applicableYield of N-terminal acetylation of desacetylthymosin beta4
    Study

    n: not reported in source

    Outcome group
    Synthesis and manufacturing · Pharmacology

    Measurements

    reaction yield
    55%
    acetylation with acetic anhydride, pH 3

    Source sentences

    Summary
    The reaction yield was 55%.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

  2. 02LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Other

    The recombinant production method gave 20 mg of highly purified thymosin beta4 from 1 L of culture.

    In plain wordsIn lab work, the method gave 20 mg of purified thymosin beta‑4 from 1 L of bacterial culture.

    Outcome
    Not applicableYield of recombinant thymosin beta4 per litre of culture
    Study

    n: not reported in source

    Outcome group
    Synthesis and manufacturing · Pharmacology

    Measurements

    yield
    20 mg
    1 L of culture

    Source sentences

    Summary
    The proposed synthetic approach to recombinant thymosin beta4 is suitable for scale-up and can provide for the medical use of highly purified preparation with a yield of 20 mg from 1 L of culture.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.